Management of stage I-II Hodgkin's disease in children
BG Leventhal
JCO Jul 1 1990: 1123–1124. [PDF]
Interleukin-2 for metastatic melanoma: treating polyuria with insulin?
IC Quirt and IF Tannock
JCO Jul 1 1990: 1125–1127. [PDF]
	Stage I-II pediatric Hodgkin's disease: long-term follow-up demonstrates equivalent survival rates following different management schemes
	SS Donaldson, SJ Whitaker, PN Plowman, MP Link, and JS Malpas
	JCO Jul 1 1990: 1128–1137. [Abstract] [PDF]
	Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cells
	MH Bar, M Sznol, MB Atkins, N Ciobanu, KC Micetich, DH Boldt, KA Margolin, FR Aronson, AA Rayner, and MJ Hawkins
	JCO Jul 1 1990: 1138–1147. [Abstract] [PDF]
	Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease
	JM Andrieu, N Ifrah, C Payen, J Fermanian, Y Coscas, and G Flandrin
	JCO Jul 1 1990: 1148–1154. [Abstract] [PDF]
	m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trial
	BW Dana, S Dahlberg, TP Miller, RJ Hartsock, S Balcerzak, CA Coltman, JO Carden, K Hartley, and RI Fisher
	JCO Jul 1 1990: 1155–1162. [Abstract] [PDF]
	Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group
	MG Conlan, M Bast, JO Armitage, and DD Weisenburger
	JCO Jul 1 1990: 1163–1172. [Abstract] [PDF]
	Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross- resistant chemotherapy and intermediate-dose radiation therapy
	DJ Straus, JJ Gaynor, J Myers, DP Merke, J Caravelli, D Chapman, J Yahalom, and BD Clarkson
	JCO Jul 1 1990: 1173–1186. [Abstract] [PDF]
	Wilm's tumor with pulmonary metastases at diagnosis: the significance of primary chemotherapy. International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee
	J de Kraker, J Lemerle, PA Voute, JM Zucker, MF Tournade, and M Carli
	JCO Jul 1 1990: 1187–1190. [Abstract] [PDF]
	Ototoxicity of preradiation cisplatin for children with central nervous system tumors
	CS Kretschmar, MP Warren, BL Lavally, S Dyer, and NJ Tarbell
	JCO Jul 1 1990: 1191–1198. [Abstract] [PDF]
	Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment
	R Champlin, J Gajewski, S Nimer, S Vollset, E Landaw, D Winston, G Schiller, and W Ho
	JCO Jul 1 1990: 1199–1206. [Abstract] [PDF]
	Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support
	FR Dunphy, G Spitzer, AU Buzdar, GN Hortobagyi, LJ Horwitz, JC Yau, JA Spinolo, S Jagannath, F Holmes, and RO Wallerstein
	JCO Jul 1 1990: 1207–1216. [Abstract] [PDF]
	A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer
	MN Levine, M Gent, WM Hryniuk, V Bramwell, H Abu-Zahra, S DePauw, A Arnold, B Findlay, L Levin, and J Skillings
	JCO Jul 1 1990: 1217–1225. [Abstract] [PDF]
	Combined high-dose carboplatin and cisplatin, and ifosfamide in previously untreated ovarian cancer patients with residual disease
	B Lund, M Hansen, OP Hansen, and HH Hansen
	JCO Jul 1 1990: 1226–1230. [Abstract] [PDF]
	Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction
	JA Ajani, JA Roth, B Ryan, M McMurtrey, TA Rich, DE Jackson, JL Abbruzzese, B Levin, L DeCaro, and C Mountain
	JCO Jul 1 1990: 1231–1238. [Abstract] [PDF]
	A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients
	JP Eder, A Elias, TC Shea, SM Schryber, BA Teicher, M Hunt, J Burke, R Siegel, LE Schnipper, and E Frei, 3d
	JCO Jul 1 1990: 1239–1245. [Abstract] [PDF]
	Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen- producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases
	YZ Patt, LM Lamki, J Shanken, JM Jessup, C Charnsangavej, JA Ajani, B Levin, B Merchant, C Halverson, and JL Murray
	JCO Jul 1 1990: 1246–1254. [Abstract] [PDF]
	The effect of right atrial catheters on infectious complications of chemotherapy in children
	J van Hoff, AT Berg, and JH Seashore
	JCO Jul 1 1990: 1255–1262. [Abstract] [PDF]
	Hypersensitivity reactions from taxol
	RB Weiss, RC Donehower, PH Wiernik, T Ohnuma, RJ Gralla, DL Trump, JR Baker, Jr, DA Van Echo, DD Von Hoff, and B Leyland-Jones
	JCO Jul 1 1990: 1263–1268. [Abstract] [PDF]
	A phase I trial of recombinant interleukin-2 combined with recombinant interferon-gamma in patients with cancer
	BG Redman, L Flaherty, TH Chou, A al-Katib, M Kraut, S Martino, B Chen, J Kaplan, and M Valdivieso
	JCO Jul 1 1990: 1269–1276. [Abstract] [PDF]
	Response criteria for phase II studies of supratentorial malignant glioma
	DR Macdonald, TL Cascino, SC Schold, Jr, and JG Cairncross
	JCO Jul 1 1990: 1277–1280. [Abstract] [PDF]
Etoposide and mesothelioma
EF Smit, HH Berendsen, and PE Postmus
JCO Jul 1 1990: 1281. [PDF]
Warfarin for small-cell lung cancer: why not?
LR Zacharski and WG Henderson
JCO Jul 1 1990: 1282–1283. [PDF]
Carboplatin dose optimization
CR Pinkerton and JR Hardy
JCO Jul 1 1990: 1283–1285. [PDF]
Management of esophageal cancer
L Coia, P Engstrom, A Paul, and G Hanks
JCO Jul 1 1990: 1285–1286. [PDF]
Combined modality therapy in esophageal cancer
LH Einhorn
JCO Jul 1 1990: 1286–1287. [PDF]
Ovarian cancer: what is poor prognosis disease?
MH Cohen
JCO Jul 1 1990: 1287–1288. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.